Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca to pay Rigel up to $1.25 billion in arthritis pact
Marketwatch
Tuesday, February 16, 2010 - 10:28am
tags:
Rigel, AstraZeneca, arthritis, partnerships
Pfizer Suit May Open Skeleton-Filled Closet on Side Effects of Cholesterol Drug Lipitor
BNET Pharma
Tuesday, February 16, 2010 - 10:26am
tags:
Pfizer, lawsuits, Lipitor, whistleblowers
FDA asks Amgen, J&J to discuss anemia drug risks
Yahoo/AP
Tuesday, February 16, 2010 - 10:23am
tags:
JNJ, Amgen, FDA, anemia, Aranesp, Procrit, Epogen
Merck Profit Rises More Than Analysts Estimated
Bloomberg
Tuesday, February 16, 2010 - 9:46am
tags:
Merck, earnings
Botox May Reduce Migraine Headaches Described as ‘Eye-Popping’
Bloomberg
Tuesday, February 16, 2010 - 9:45am
tags:
Botox, Allergan, migraines
CombinatoRx founder heads new launch
Bizjournals.com
Tuesday, February 16, 2010 - 9:43am
tags:
CombinatoRx, personalized medicine, Foundation Medicine
FDA Delay Leaves Cadence Tapping Feet Once Again
Seeking Alpha
Tuesday, February 16, 2010 - 9:41am
tags:
FDA, Cadence Pharmaceuticals, Ofirmev
Boston Scientific to Cut up to 1,300 Employees: Biotech's Weekly Mishaps Report
Seeking Alpha
Tuesday, February 16, 2010 - 9:38am
tags:
Boston Scientific, layoffs, Cadence Pharmaceuticals, Oxigene
3SBio, Ascentage Form Alliance to Develop Cancer Drugs
Seeking Alpha
Tuesday, February 16, 2010 - 9:36am
tags:
cancer, partnerships, Ascentage, 3SBio, China
Cubist Pharmaceuticals: A Drug Stock With Potential for Solid Gain
Seeking Alpha
Tuesday, February 16, 2010 - 9:34am
tags:
Cubist Pharmaceuticals
Teva swings to profit; adjusted net up 18%
Marketwatch
Tuesday, February 16, 2010 - 9:32am
tags:
Teva Pharmaceuticals, earnings
China Biotech Week in Review
Seeking Alpha
Tuesday, February 16, 2010 - 9:30am
tags:
China, 3SBio, NeoStem, Simcere, Tianyin Pharmaceutical, Celsis In Vitro
Teva and Novartis reach settlement on Famvir suit
Marketwatch
Tuesday, February 16, 2010 - 9:29am
tags:
Teva Pharmaceuticals, Novartis, lawsuits, settlements, Famvir
Analysts: Effient won't be a blockbuster
Fierce Pharma
Tuesday, February 16, 2010 - 9:28am
tags:
Effient, blood thinners, Eli Lilly
Pharmas Walking the Patent Tightrope
Seeking Alpha
Tuesday, February 16, 2010 - 9:26am
tags:
Alzheimer's disease, Teva Pharmaceuticals, Janssen Pharmaceuticals, Eli Lilly, patents, Actavis
AstraZeneca Gets a Healthy Shot With Crestor
Seeking Alpha
Tuesday, February 16, 2010 - 9:25am
tags:
AstraZeneca, Crestor, statins, Pfizer
Cell Therapeutics Still Waiting on Its Diagnosis
Seeking Alpha
Tuesday, February 16, 2010 - 9:23am
tags:
Cell Therapeutics, pixantrone, Novartis
Takeda announced today that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix
PR-Canada.net
Saturday, February 13, 2010 - 12:22pm
tags:
Takeda, PPIs, Plavix
AstraZeneca reassures investors on earnings
The News Journal
Saturday, February 13, 2010 - 11:34am
tags:
AstraZeneca
QIAGEN and Celera Establish Distribution Agreement for Respiratory Pathogen Panel
PR-USA.net
Saturday, February 13, 2010 - 11:33am
tags:
Qiagen, Celra

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.